1.
Chinese Journal of Pharmacoepidemiology
; (4)2006.
Artículo
en Chino
| WPRIM (Pacífico Occidental)
| ID: wpr-683540
RESUMEN
0.05)was found in the 2 groups.The costs of the 2 groups were 3270.84 yuan and 10 873.20 yuan respectively,and the cost-effectiveness rates were 37.38 and 117.55 respectively.Conclusion:Scheme A is an effective,safe and economical scheme in the treatment of CHB.